Dominari Holdings Inc
Change company Symbol lookup
Select an option...
DOMH Dominari Holdings Inc
SMLR Semler Scientific Inc
GME GameStop Corp
DCO Ducommun Inc
QSI Quantum-Si Inc
TLS Telos Corp
ONB Old National Bancorp
TIG Trean Insurance Group Inc
NVDA NVIDIA Corp
DICE Dice Therapeutics Inc
Go

Health Care : Biotechnology | Small Cap Value
Company profile

Dominari Holdings Inc., formerly AIkido Pharma Inc., is a biotechnology company. The Company has a diverse portfolio of small-molecule anticancer and antiviral therapeutics in development. The Company’s pipeline consists of patented technology from universities and researchers. The Company advances its therapeutic drug pipeline through a collaboration with educational institutions, including the University of Texas at Austin, the University of Maryland, Baltimore and Wake Forest University. Its oncology therapeutics include treatments for pancreatic cancer, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is also developing a broad-spectrum antiviral platform, in which the lead compounds have activity against multiple viruses including Influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2, the cause of COVID-19. Its pancreatic drug candidate, DHA-dFdC, is a chemotherapy treatment for advanced pancreatic cancer.

Closing Price
$2.98
Day's Change
-0.29 (-8.87%)
Bid
--
Ask
--
B/A Size
--
Day's High
3.36
Day's Low
2.88
Volume
(Heavy Day)
Volume:
63,837

10-day average volume:
33,732
63,837

Appian To Announce Fourth Quarter and Full Year 2022 Financial Results on February 16

4:35 pm ET January 19, 2023 (Globe Newswire) Print
Appian To Announce Fourth Quarter and Full Year 2022 Financial Results on February 16GlobeNewswireJanuary 19, 2023

MCLEAN, Va., Jan. 19, 2023 (GLOBE NEWSWIRE) -- Appian (Nasdaq: APPN) today announced that it will release financial results for the fourth quarter and full year ended December 31, 2022, following the close of market on Thursday, February 16, 2023. The company will host a conference call and live webcast to review its financial results and business outlook.

Conference Call Details

The conference call will begin at 4:30 p.m. Eastern Time. To access the call, please use this Registration Link. Once registered, participants can dial in the same way they always have, using their phone with a dial in and PIN, or they can choose the Call Me option for instant dial to their phone. The conference call will also be available live via webcast on the Investor Relations page of the Company's website at http://investors.appian.com.

A webcast replay of the conference call can be accessed at http://investors.appian.com after the conclusion of the live conference call.

About Appian



Appian is the unified platform for change. We accelerate customers' businesses by discovering, designing, and automating their most important processes. The Appian Low-Code Platform combines the key capabilities needed to get work done faster, Process Mining + Workflow + Automation, in a unified low-code platform. Appian is open, enterprise-grade and trusted by industry leaders. For more information, visit appian.com.

Investor Contact

Srinivas Anantha, CFA

703-442-8844

sri.anantha@appian.com

Media Contact

Ben Farrell

703-442-1067

ben.farrell@appian.com

Source: Appian Corporation



Primary Logo

comtex tracking

COMTEX_422950190/2010/2023-01-19T16:35:00

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.